Key Points

• Safety Concerns: How will the "Loss of Pulse Detection" feature on the Pixel Watch 3 improve emergency response times and save lives in cardiac arrest situations?r
• Regulatory Oversight: What implications does this FDA clearance have for other smartwatch manufacturers and their similar health-related features?r
• User Adoption: Will consumers be willing to adopt a wearable device solely for its life-saving capabilities, or will other factors like design, pricing, and ecosystem considerations influence purchasing decisions?Summary (100 words):r Google has received FDA clearance for the Pixel Watch 3's "Loss of Pulse Detection" feature, allowing it to launch in the US at the end of March. This feature can detect when a user's heart stops beating due to events like primary cardiac arrest, respiratory, or circulatory failure. The implications of this technology are significant, with potential to improve emergency response times and save lives. However, concerns around regulatory oversight and user adoption remain. As the first smartwatch to receive FDA clearance for such a feature, Google's move sets a precedent for other manufacturers to follow suit.